RE: What's next for NCSTI think $4 is fair value for NCST as they have tough competition for Acticoat business and no other products expected for years.
WED is concentrating on IFire and the cash is needed there. I believe they were hoping to raise more cash by selling controlling interest in NCST next year if their Phase 2 tests were successful.